-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Milestone Pharmaceuticals (MIST)
-
-
-
-
-
-
-
Milestone Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Shares and Pre-Funded Warrants
-
-
-
-
-
-
-
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
20,596 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

